| 期刊全稱(chēng) | Bioimaging in Neurodegeneration | | 影響因子2023 | Patricia A. Broderick,David N. Rahni,Edwin H. Kolo | | 視頻video | http://file.papertrans.cn/188/187138/187138.mp4 | | 發(fā)行地址 | Includes supplementary material: | | 學(xué)科分類(lèi) | Contemporary Neuroscience | | 圖書(shū)封面 |  | | 影響因子 | Bioimaging is in the forefront of medicine for the diagnosis and helps to predict the progression of AD via mild cognitive treatment of neurodegenerative disease. Conventional magnetic impairment (MCI) studies. resonance imaging (MRI) uses interactive external magnetic fields Novel neuroimaging technologies, such as neuromolecular and resonant frequencies of protons from water molecules. imaging (NMI) with a series of newly developed BRODERICK ? However, newer sequences, such as magnetization-prepared rapid PROBE sensors, directly image neurotransmitters, precursors, acquisition gradient echo (MPRAGE), are able to seek higher and metabolites in vivo, in real time and within seconds, at separate levels of anatomic resolution by allowing more rapid temporal and selective waveform potentials. NMI, which uses an imaging. Magnetic resonance spectroscopy (MRS) images electrochemical basis for detection, enables the differentiation of metabolic changes, enabling underlying pathophysiologic neurodegenerative diseases in patients who present with mesial dysfunction in neurodegeneration to be deciphered. Neuro- versus neocortical temporal lobe epilepsy. In fact, NMI has some 1 chemicals visi | | Pindex | Book 20051st edition |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-12 09:10
發(fā)表于 2025-3-21 17:43:53
